AAAAAA
Results:
1-18
|
Results: 18
Authors:
MONNET I
BRIENZA S
HUGRET F
VOISIN S
GASTIABURU J
SALTIEL JC
SOULIE P
ARMAND JP
CVITKOVIC E
DECREMOUX H
Citation: I. Monnet et al., PHASE-II STUDY OF OXALIPLATIN IN POOR-PROGNOSIS NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 34(7), 1998, pp. 1124-1127
Authors:
GERARD B
BLEIBERG H
VANDAELE D
GIL T
HENDLISZ A
DILEO A
FERNEZ B
BRIENZA S
Citation: B. Gerard et al., OXALIPLATIN COMBINED TO 5-FLUOROURACIL AND FOLINIC ACID - AN EFFECTIVE THERAPY IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Anti-cancer drugs, 9(4), 1998, pp. 301-305
Authors:
GAMELIN E
BOISDRONCELLE M
LEBOUIL A
TURCANT A
CAILLEUX A
KRIKORIAN A
BRIENZA S
CVITKOVIC E
LARRA F
ROBERT J
ALLAIN P
Citation: E. Gamelin et al., DETERMINATION OF UNBOUND PLATINUM AFTER OXALIPLATIN ADMINISTRATION - COMPARISON OF CURRENTLY AVAILABLE METHODS AND INFLUENCE OF VARIOUS PARAMETERS, Anti-cancer drugs, 9(3), 1998, pp. 223-228
Authors:
GERMANN N
SOULIE P
BRIENZA S
ROTARSKY M
EMILE JF
DIPALMA M
MUSSET M
REYNES M
CVITKOVIC E
MISSET JL
Citation: N. Germann et al., OXALIPLATIN (LOHP) - A NEW PLATINUM ANALOG ACTIVE ON REFRACTORY RELAPSED NON-HODGKINS-LYMPHOMA/, Annals of oncology, 9, 1998, pp. 528-528
Authors:
DEBRAUD F
MUNZONE E
NOLE F
DEPAS T
BIFFI R
BRIENZA S
AAPRO MS
Citation: F. Debraud et al., SYNERGISTIC ACTIVITY OF OXALIPLATIN AND 5-FLUOROURACIL IN PATIENTS WITH METASTATIC COLORECTAL-CANCER WITH PROGRESSIVE DISEASE WHILE ON OR AFTER 5-FLUOROURACIL, American journal of clinical oncology, 21(3), 1998, pp. 279-283
Authors:
EXTRA JM
MARTY M
BRIENZA S
MISSET JL
Citation: Jm. Extra et al., PHARMACOKINETICS AND SAFETY PROFILE OF OXALIPLATIN, Seminars in oncology, 25(2), 1998, pp. 13-22
Authors:
GAMELIN E
LEBOUIL A
BOISDRONCELLE M
TURCANT A
DELVA R
CAILLEUX A
KRIKORIAN A
BRIENZA S
CVITKOVIC E
ROBERT J
LARRA F
ALLAIN P
Citation: E. Gamelin et al., CUMULATIVE PHARMACOKINETIC STUDY OF OXALIPLATIN, ADMINISTERED EVERY 3WEEKS, COMBINED WITH 5-FLUOROURACIL IN COLORECTAL-CANCER PATIENTS, Clinical cancer research, 3(6), 1997, pp. 891-899
OXALIPLATIN (LOHP) AND 5-FLUOROURACIL (5-FU) SYNERGISM IN ADVANCED COLORECTAL-CANCER PATIENTS (ACRC)
Authors:
MEYER V
DELVA R
GAMELIN E
LAMEZEC B
MAILLART P
DANQUECHINDORVAL E
LORTHOLARY A
BOISDRONCELLE M
MAIGRE M
BRIENZA S
CVITKOVIC E
LARRA F
Citation: V. Meyer et al., OXALIPLATIN (LOHP) AND 5-FLUOROURACIL (5-FU) SYNERGISM IN ADVANCED COLORECTAL-CANCER PATIENTS (ACRC), European journal of cancer, 33, 1997, pp. 746-746
Authors:
SOULIE P
RAYMOND E
BRIENZA S
CVITKOVIC E
Citation: P. Soulie et al., OXALIPLATIN - THE FIRST DACH PLATINUM IN CLINICAL-PRACTICE, Bulletin du cancer, 84(6), 1997, pp. 665-673
Authors:
DEGARDIN M
CAPPELAERE P
KRAKOWSKI I
FARGEOT P
CUPISSOL D
BRIENZA S
Citation: M. Degardin et al., PHASE-II TRIAL OF OXALIPLATIN (L-OHP) IN ADVANCED, RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, European journal of cancer. Part B, Oral oncology, 32B(4), 1996, pp. 278-279
Authors:
CHOLLET P
BENSMAINE MA
BRIENZA S
DELOCHE C
CURE H
CAILLET H
CVITKOVIC E
Citation: P. Chollet et al., SINGLE-AGENT ACTIVITY OF OXALIPLATIN IN HEAVILY PRETREATED ADVANCED EPITHELIAL OVARIAN-CANCER, Annals of oncology, 7(10), 1996, pp. 1065-1070
Authors:
MACHOVER D
DIAZRUBIO E
DEGRAMONT A
SCHILF A
GASTIABURU JJ
BRIENZA S
ITZHAKI M
METZGER G
NDAW D
VIGNOUD J
ABAD A
FRANCOIS E
GAMELIN E
MARTY M
SASTRE J
SEITZ JF
YCHOU M
Citation: D. Machover et al., 2 CONSECUTIVE PHASE-II STUDIES OF OXALIPLATIN (L-OHP) FOR TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA WHO WERE RESISTANT TO PREVIOUS TREATMENT WITH FLUOROPYRIMIDINES, Annals of oncology, 7(1), 1996, pp. 95-98
Authors:
BERTHEAULTCVITKOVIC F
JAMI A
ITHZAKI M
BRUMMER PD
BRIENZA S
ADAM R
KUNSTLINGER F
BISMUTH H
MISSET JL
LEVI F
Citation: F. Bertheaultcvitkovic et al., BIWEEKLY INTENSIFIED AMBULATORY CHRONOMODULATED CHEMOTHERAPY WITH OXALIPLATIN, FLUOROURACIL, AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Journal of clinical oncology, 14(11), 1996, pp. 2950-2958
Authors:
GARUFI C
BENSMAINE MA
BRIENZA S
MISSET JL
ASCHELTER A
PACE R
BERTHEAULTCVITKOVIC F
TERZOLI E
LEVI F
Citation: C. Garufi et al., ADDITION OF OXALIPLATIN (L-OHP(R)) TO CHRONOMODULATED (CM) 5-FLUOROURACIL (5-FU) AND FOLINIC ACID (FA) FOR REVERSAL OF ACQUIRED CHEMORESISTANCE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER (ACC), European journal of cancer, 31A, 1995, pp. 124-124
Authors:
LEVI F
MACHOVER D
MARTY M
DIAZRUBIO E
DEGRAMONT A
GARUFI C
ITZHAKI M
CVITKOVIC E
BENSMAINE MA
BRIENZA S
MISSET JL
Citation: F. Levi et al., OXALIPLATIN (L-OHP(R)) - SUMMARY OF RESULTS IN ADVANCED COLORECTAL-CANCER (ACC), European journal of cancer, 31A, 1995, pp. 738-738
Authors:
BRIENZA S
VIGNOUD J
ITZHAKI M
KRIKORIAN M
Citation: S. Brienza et al., OXALIPLATIN (L-OHP(R)) - GLOBAL SAFETY IN 682 PATIENTS (PTS), European journal of cancer, 31A, 1995, pp. 933-933
Authors:
METZGER G
MASSARI C
ETIENNE MC
COMISSO M
BRIENZA S
TOUITOU Y
MILANO G
BASTIAN G
MISSET JL
LEVI F
Citation: G. Metzger et al., SPONTANEOUS OR IMPOSED CIRCADIAN CHANGES IN PLASMA-CONCENTRATIONS OF 5-FLUOROURACIL COADMINISTERED WITH FOLINIC ACID AND OXALIPLATIN - RELATIONSHIP WITH MUCOSAL TOXICITY IN PATIENTS WITH CANCER, Clinical pharmacology and therapeutics, 56(2), 1994, pp. 190-201
Authors:
BERTHEAULTCVITKOVIC F
LEVI F
SOUSSAN S
BRIENZA S
ADAM R
ITZHAKI M
MISSET JL
BISMUTH H
Citation: F. Bertheaultcvitkovic et al., CIRCADIAN RHYTHM-MODULATED CHEMOTHERAPY WITH HIGH-DOSE 5-FLUOROURACIL- A PILOT-STUDY IN PATIENTS WITH PANCREATIC ADENOCARCINOMA, European journal of cancer, 29A(13), 1993, pp. 1851-1854
Risultati:
1-18
|